was successfully added to your cart.

Your SEO optimized title page contents

Illinois Department of Public Health Hearing on May 5 | Patient Registry

IL Patient

Yesterday, I had the pleasure of attending the Illinois Department of Public Health public hearing regarding the proposed rules that were published last month. The hearing is the first of two scheduled meetings to gather public opinion on the rules that mainly focus on patient/dispensary relationships, as well as cannabis infused products. Other aspects of the Compassionate Use of Medical Cannabis Pilot Program Act (CUMCPPA) are handled by the Department of Agriculture, Revenue, and Financial and Professional Regulation.

Many of those who offered up their opinions shared the sentiment that the State and more specifically, the Department, has been dragging their feet on the roll out of this program. While many thanked the department for their hard work, they also felt that they need to move quicker. Many argued that there are other states that are working out the details as they go, and if IL could follow the same model, patients wouldn't be suffering as much as they are now.

Many were also skeptical about the background check process for patients looking to register for a card. Despite being lowered in the revised rules released on April 18, the fees for both the card and the fingerprinting, as argued by several, will keep medicine out of the hands of deserving patients living in low income families. Another resident argued that requiring background checks for patients is the opposite of being compassionate.

Comments also came in regarding caregiver requirements. As the law is written now, caregivers must be residents of the state of Illinois. A few concerned citizens shared the fact that many sick patients receive their care from relatives and family members coming in from out of state.

The Departments and the State still have some things to work out, but the overall process is moving forward. The Department of Public Health will hold it's next hearing in Springfield on May 21st.

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply